For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Alx Oncology Holdings Inc’s stock clocked out at $1.49, up 1.36% from its previous closing price of $1.47. In other words, the price has increased by $1.36 from its previous closing price. On the day, 0.55 million shares were traded. ALXO stock price reached its highest trading level at $1.55 during the session, while it also had its lowest trading level at $1.47.
Ratios:
To gain a deeper understanding of ALXO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.82 and its Current Ratio is at 4.82. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on March 08, 2024, Downgraded its rating to Hold and sets its target price to $14 from $10 previously.
On December 08, 2023, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $8 to $18.
Jefferies Downgraded its Buy to Hold on December 22, 2021, whereas the target price for the stock was revised from $65 to $25.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 14 ’24 when Pinto Shelly sold 564 shares for $2.58 per share. The transaction valued at 1,455 led to the insider holds 91,549 shares of the business.
Randolph Sophia sold 1,365 shares of ALXO for $3,522 on Aug 14 ’24. The CHIEF MEDICAL OFFICER now owns 325,711 shares after completing the transaction at $2.58 per share. On Aug 14 ’24, another insider, Pons Jaume, who serves as the PRESIDENT & CSO of the company, sold 1,937 shares for $2.58 each. As a result, the insider received 4,997 and left with 591,510 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALXO now has a Market Capitalization of 78587216 and an Enterprise Value of -53683636.
Stock Price History:
Over the past 52 weeks, ALXO has reached a high of $17.83, while it has fallen to a 52-week low of $1.19. The 50-Day Moving Average of the stock is -5.32%, while the 200-Day Moving Average is calculated to be -80.36%.
Shares Statistics:
It appears that ALXO traded 686.52K shares on average per day over the past three months and 968600 shares per day over the past ten days. A total of 49.95M shares are outstanding, with a floating share count of 34.33M. Insiders hold about 34.91% of the company’s shares, while institutions hold 58.46% stake in the company. Shares short for ALXO as of 1730332800 were 7842727 with a Short Ratio of 11.42, compared to 1727654400 on 9319104. Therefore, it implies a Short% of Shares Outstanding of 7842727 and a Short% of Float of 25.77.
